Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 1216K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Delamarre, L. Articles by Trombetta, E. S. Search for Related Content PubMed PubMed Citation Articles by Delamarre, L. Articles by Trombetta, E. S. Related Collections Related Article Social Bookmarking                            What's this?

¹ Department of Cell Biology and ² Section of Immunobiology, Ludwig Institute for Cancer Research, Yale University School of Medicine, New Haven, CT 06520
³ Cancer Institute, New York University School of Medicine, New York, NY, 10016

CORRESPONDENCE Ira Mellman: ira.mellman{at}yale.edu

T cells recognize protein antigens as short peptides processed and displayed by antigen-presenting cells. However, the mechanism of peptide selection is incompletely understood, and, consequently, the differences in the immunogenicity of protein antigens remain largely unpredictable and difficult to manipulate. In this paper we show that the susceptibility of protein antigens to lysosomal proteolysis plays an important role in determining immunogenicity in vivo. We compared the immunogenicity of proteins with the same sequence (same T cell epitopes) and structure (same B cell epitopes) but with different susceptibilities to lysosomal proteolysis. After immunizing mice with each of the proteins adsorbed onto aluminum hydroxide as adjuvant, we measured serum IgG responses as a physiological measure of the antigen's ability to be presented on major histocompatibility complex class II molecules and to prime CD4⁺ T cells in vivo. For two unrelated model antigens (RNase and horseradish peroxidase), we found that only the less digestible forms were immunogenic, inducing far more efficient T cell priming and antibody responses. These findings suggest that stability to lysosomal proteolysis may be an important factor in determining immunogenicity, with potential implications for vaccine design.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Call, M. J., Xing, X., Cuny, G. D., Seth, N. P., Altmann, D. M., Fugger, L., Krogsgaard, M., Stein, R. L., Wucherpfennig, K. W. (2009). In Vivo Enhancement of Peptide Display by MHC Class II Molecules with Small Molecule Catalysts of Peptide Exchange. J. Immunol. 182: 6342-6352 [Abstract] [Full Text]  
• Giodini, A., Rahner, C., Cresswell, P. (2009). Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells. Proc. Natl. Acad. Sci. USA 106: 3324-3329 [Abstract] [Full Text]  
• Berger, A. C., Roche, P. A. (2009). MHC class II transport at a glance. J. Cell Sci. 122: 1-4 [Full Text]  
• Garulli, B., Stillitano, M. G., Barnaba, V., Castrucci, M. R. (2008). Primary CD8+ T-Cell Response to Soluble Ovalbumin Is Improved by Chloroquine Treatment In Vivo. CVI 15: 1497-1504 [Abstract] [Full Text]  
• Walseng, E., Bakke, O., Roche, P. A. (2008). Major Histocompatibility Complex Class II-Peptide Complexes Internalize Using a Clathrin- and Dynamin-independent Endocytosis Pathway. J. Biol. Chem. 283: 14717-14727 [Abstract] [Full Text]  
• Bhowmick, S., Ravindran, R., Ali, N. (2008). gp63 in Stable Cationic Liposomes Confers Sustained Vaccine Immunity to Susceptible BALB/c Mice Infected with Leishmania donovani. Infect. Immun. 76: 1003-1015 [Abstract] [Full Text]  
• Bins, A. D., Wolkers, M. C., van den Boom, M. D., Haanen, J. B. A. G., Schumacher, T. N. M. (2007). In Vivo Antigen Stability Affects DNA Vaccine Immunogenicity. J. Immunol. 179: 2126-2133 [Abstract] [Full Text]  
• Delamarre, L., Couture, R., Mellman, I., Trombetta, E. S. (2006). Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. JCB 174: i9-i9 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS